Pregnancy with recurrent Sertoli- Leydig cell tumour
DOI:
https://doi.org/10.7439/ijbar.v5i9.845Abstract
Sertoli -Leydig cell tumor (SLCT) is a rare variety ovarian tumor that belongs to the group of sex-cord stromal tumors. These constitute less than 0.5% of malignant ovarian tumors. A recurrence of Sertoli-Leydig cell tumor of right ovary in a 21-year-old pregnant woman with twenty weeks pregnancy is reported. Oligo-menorrhoea, obesity, mild hirsutism and other features of virilism were associated with the condition. Normal level testosterone and alpha-fetoprotein (AFP) were found preoperatively.Exploratory laparotomy and right sided salpingo- ovariotomy was performed in fifth month of pregnancy, under general anaesthesia. There were no pelvic or peritoneal metastatic deposits. Histopathology and immuno-histo chemistry confirmed the diagnosis of poorly differentiated Sertoli- Leydig cell tumour. Onco-surgeon and physician were consulted for tumor surveillance and further management during pregnancy. It was decided to start cancer chemotherapy after the delivery of baby. After the laparotomy ,patient had uneventful antenatal period .She was delivered by an elective caesarean section at the completion of 38 weeks. A healthy male baby with 3 kg birth weight was born with good Apgar score and without any congenital malformation. Peritoneal metastatic deposit of 3 to 4 cms in size were found in the pelvic region during caesarean section .These tumour deposits were removed during caesarean section and sent for histopathology .Histopathology report was suggestive of poorly differentiated Sertoli- Leydig cell tumour. Patient was treated with paclitaxel and carboplatin regemen in the postpartum period. This is one of the rare reports on a Sertoli- Leydig cell tumor which showed recurrence and rapid growth during pregnancy.Downloads
Download data is not yet available.
Downloads
Published
2014-09-30
Issue
Section
Case Report
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
Pregnancy with recurrent Sertoli- Leydig cell tumour. (2014). International Journal of Biomedical and Advance Research, 5(9), 459-461. https://doi.org/10.7439/ijbar.v5i9.845